Home - Products - Others - Other Targets - 5,6,7,3',4'-Pentamethoxyflavanone

5,6,7,3',4'-Pentamethoxyflavanone

CAS No. 104193-93-3

5,6,7,3',4'-Pentamethoxyflavanone( —— )

Catalog No. M32339 CAS No. 104193-93-3

5,6,7,3',4'-pentamethoxyflavanone exhibited anti-proliferative activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5,6,7,3',4'-Pentamethoxyflavanone
  • Note
    Research use only, not for human use.
  • Brief Description
    5,6,7,3',4'-pentamethoxyflavanone exhibited anti-proliferative activities.
  • Description
    5,6,7,3',4'-pentamethoxyflavanone exhibited anti-proliferative activities. 5,6,7,3',4'-Pentamethoxyflavanone inhibit PCSK9 mRNA expression with IC50 values of 21.4. 5,6,7,3',4'-pentamethoxyflavanone could also significantly inhibit NO production.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    104193-93-3
  • Formula Weight
    374.4
  • Molecular Formula
    C20H22O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bioorg Chem . 2020 Jun;99:103869.
molnova catalog
related products
  • 5,6-Epoxyergosterol

    5,6-Epoxyergosterol is derived from the endophytic fungus Phyllosticta capitalensis.

  • Sotetsuflavone

    Sotetsuflavone is a potent inhibitor of DENV-NS5 RdRp (Dengue virus NS5 RNA-dependent RNA polymerase) with an IC50 of 0.16 μM, is the most active compound of this series.

  • Ramucirumab

    Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.